Pharmacological activation of a novel p53-dependent S-phase checkpoint involving CHK-1. [electronic resource]
- Cell death & disease May 2011
- e160 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2041-4889
10.1038/cddis.2011.42 doi
Apoptosis--drug effects Ataxia Telangiectasia--metabolism Breast Neoplasms--genetics Cell Cycle Proteins--genetics Cell Line, Tumor Checkpoint Kinase 1 Colorectal Neoplasms--genetics DNA Damage--drug effects DNA Replication--drug effects Female Furans--pharmacology Gene Knockdown Techniques Histones--genetics Humans Hypoxia--genetics Hypoxia-Inducible Factor 1, alpha Subunit--antagonists & inhibitors Osteosarcoma--genetics Phosphorylation--drug effects Protein Kinase Inhibitors--pharmacology Protein Kinases--biosynthesis Replication Origin--drug effects S Phase--drug effects Signal Transduction--drug effects Transfection Tumor Suppressor Protein p53--genetics